Our Recommendations
New Publications
- Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map-english and french (2024)
- Strategic framework for the elimination of visceral leishmaniasis as a public health problem in eastern Africa 2023–2030 (2024)
- Global report on neglected tropical diseases 2023 (2023)
- Global leishmaniasis surveillance: 2021, assessing the impact of the COVID-19 pandemic (2022)
- Leishmaniasis is a vector-borne disease (2022)
Filter
30
Featured
Language
Document type
Studies & Reports
27
Strategic & Response Plan
2
Fact sheets
1
Countries / Regions
Global
14
Latin America and the Carribbean
4
Kenya
2
Asia
2
Brazil
2
Sudan
2
Ethiopia
2
South Sudan
2
Somalia
2
India
2
Nepal
1
Turkey
1
China
1
Senegal
1
Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western and Central Europe
1
East and Southern Africa
1
Southern Africa
1
Bangladesh
1
Eastern Europe
1
Greece
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
11
Disease Prevention & Control
9
Health System Strengthening
2
Studies & Reports
2
Pharmacy & Technologies
2
Gender
1
Vector Control
1
NTDs & Others
1
Parasitology
1
Toolboxes
Arab world’s growing contribution to global leishmaniasis research (1998–2017): a bibliometric study
Leishmaniasis is a parasitic disease caused by a protozoan of the Leishmania genus, and is considered a neglected tropical disease. It still remains a main public health concern at global level and in Arab world mainly in low-income countries. Therefore, this study was designed to evaluate the Arab ...
Leishmaniasis is a parasitic disease caused by intracellular protozoan parasites of the genus Leishmania (Trypanosomatidae family); it is endemic in more than 98 countries worldwide [1]. Visceral (VL) and cutaneous (CL) leishmaniasis are the most common forms of the disease. VL causes a systemic dis...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
Leishmaniasis is a climate-sensitive disease. Changes in
temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their
survival and population sizes. Increased temperatures shorten
vector development time, reduce Leishmania p...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs). This work is described in the NTD ...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Surveillance mondiale de la leishmaniose: 2021, évaluation de l’impact de la pandémie de COVID-19
The aims of this report are to update the results of the GHO leishmaniasis indicators reported by Member States to WHO up to 2021, to describe specific indicators of gender and age distribution, re...
